| 1 |
Qiao Y, Suri F K, Zhang Y, et al. Racial differences in prevalence and risk for intracranial atherosclerosis in a us community-based population [J]. JAMA Cardiol, 2017, 2(12): 1341-1348.
|
| 2 |
Sacco RL, Kargman DE, Gu Q, et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study [J]. Stroke, 1995, 26(1): 14-20.
|
| 3 |
Mehndiratta MM, Khan M, Mehndiratta P, et al. Stroke in Asia: geographical variations and temporal trends [J]. J Neurol Neurosurg Psychiatry, 2014, 85(12): 1308-1312.
|
| 4 |
Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review [J]. Stroke, 1986, 17(4): 648-655.
|
| 5 |
Wang Y, Zhao X, Liu L, et al. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese intracranial atherosclerosis (CICAS) study [J]. Stroke, 2014, 45(3): 663-669.
|
| 6 |
Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies [J]. Neurology, 2004, 62(4): 569-573.
|
| 7 |
Wong KS, Li H. Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis [J]. Stroke, 2003, 34(10): 2361-2366.
|
| 8 |
Derdeyn CP, Chimowitz MI, Lynn MJ, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial [J]. Lancet, 2014, 383(9914): 333-341.
|
| 9 |
Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis [J]. N Engl J Med, 2005, 352(13): 1305-1316.
|
| 10 |
Sangha RS, Naidech AM, Corado C, et al. Challenges in the medical management of symptomatic intracranial stenosis in an urban setting [J]. Stroke, 2017, 48(8): 2158-2163.
|
| 11 |
Nam KW, Kwon HM, Lim JS, et al. Clinical relevance of abnormal neuroimaging findings and long-term risk of stroke recurrence [J]. Eur J Neurol, 2017, 24(11): 1348-1354.
|
| 12 |
Gouveia A, Sargento-Freitas J, Penetra J, et al. Recurrence in intracranial atherosclerotic disease: a stenosis-based analysis [J]. J Stroke Cerebrovasc Dis, 2014, 23(8): 2080-2084.
|
| 13 |
Wang PQ, Liu JJ, Wang AP, et al. Recurrent ischemic events and risk factors in patients with symptomatic intracranial artery stenosis [J]. Eur Rev Med Pharmacol Sci, 2015, 19(14): 2608-2613.
|
| 14 |
Planas-Ballve A, Crespo AM, Aguilar LM, et al. The Barcelona-Asymptomatic Intracranial Atherosclerosis study: subclinical intracranial atherosclerosis as predictor of long-term vascular events [J]. Atherosclerosis, 2019, 282: 132-136.
|
| 15 |
Famakin BM, Chimowitz MI, Lynn MJ, et al. Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis [J]. Stroke, 2009, 40(6): 1999-2003.
|
| 16 |
Kim BS, Chung PW, Park KY, et al. Burden of intracranial atherosclerosis is associated with long-term vascular outcome in patients with ischemic stroke [J]. Stroke, 2017, 48(10): 2819-2826.
|
| 17 |
Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis [J]. Circulation, 2006, 113(4): 555-563.
|
| 18 |
Sun P, Liu L, Pan Y, et al. Intracranial Atherosclerosis Burden and Stroke Recurrence for Symptomatic Intracranial Artery Stenosis (sICAS) [J]. Aging Dis, 2018, 9(6): 1096-1102.
|
| 19 |
Liebeskind DS, Kosinski AS, Lynn MJ, et al. Noninvasive fractional flow on MRA predicts stroke risk of intracranial stenosis [J]. J Neuroimaging, 2015, 25(1): 87-91.
|
| 20 |
Leng X, Scalzo F, Ip HL, et al. Computational fluid dynamics modeling of symptomatic intracranial atherosclerosis may predict risk of stroke recurrence [J]. PLoS One, 2014, 9(5): e97531.
|
| 21 |
Lau AY, Wong EH, Wong A, et al. Significance of good collateral compensation in symptomatic intracranial atherosclerosis [J]. Cerebrovasc Dis, 2012, 33(6): 517-524.
|
| 22 |
Liebeskind DS, Cotsonis GA, Saver JL, et al. Collaterals dramatically alter stroke risk in intracranial atherosclerosis [J]. Ann Neurol, 2011, 69(6): 963-974.
|
| 23 |
Liebeskind DS, Cotsonis GA, Saver JL, et al. Collateral circulation in symptomatic intracranial atherosclerosis [J]. J Cereb Blood Flow Metab, 2011, 31(5): 1293-1301.
|
| 24 |
Ran Y, Wang Y, Zhu M, et al. Higher plaque burden of middle cerebral artery is associated with recurrent ischemic stroke: a quantitative magnetic resonance imaging study [J]. Stroke, 2020, 51(2): 659-662.
|
| 25 |
Turan TN, Bonilha L, Morgan PS, et al. Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease [J]. J Neuroimaging, 2011, 21(2): e159-e161.
|
| 26 |
Xu Y, Yuan C, Zhou Z, et al. Co-existing intracranial and extracranial carotid artery atherosclerotic plaques and recurrent stroke risk: a three-dimensional multicontrast cardiovascular magnetic resonance study [J]. J Cardiovasc Magn Reson, 2016, 18(1): 90.
|
| 27 |
宋晓微, 魏宸铭, 徐文灯, 等. 颅内动脉粥样硬化卒中患者斑块内出血发生率及相关因素分析 [J]. 中华医学杂志, 2020, 100(33): 2622-2627.
|
| 28 |
Wang Y, Liu X, Wu X, et al. Culprit intracranial plaque without substantial stenosis in acute ischemic stroke on vessel wall MRI: a systematic review [J]. Atherosclerosis, 2019, 287: 112-121.
|
| 29 |
Kim JM, Jung KH, Sohn CH, et al. Intracranial plaque enhancement from high resolution vessel wall magnetic resonance imaging predicts stroke recurrence [J]. Int J Stroke, 2016, 11(2): 171-179.
|
| 30 |
董爱勤, 王春雨, 刘辉. 高分辨率磁共振检测颅内动脉粥样硬化易损斑块与中老年复发脑梗死的关系 [J]. 脑与神经疾病杂志, 2019, 27(2):73-76.
|
| 31 |
Waters MF, Hoh BL, Lynn MJ, et al. Factors associated with recurrent ischemic stroke in the medical group of the SAMMPRIS trial [J]. JAMA Neurol, 2016, 73(3): 308-315.
|
| 32 |
Wabnitz AM, Derdeyn CP, Fiorella DJ, et al. Hemodynamic markers in the anterior circulation as predictors of recurrent stroke in patients with intracranial stenosis [J]. Stroke, 2018: A118020840.
|